COVID-19 drug trial pulled before it even started

NCT ID NCT05552625

First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study aimed to test whether an experimental drug called TADIOS could help people hospitalized with mild to moderate COVID-19 recover faster. It was designed for adults aged 18 to 65 who had a confirmed first-time COVID-19 infection. However, the trial was withdrawn before enrolling any participants, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID - 19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chaitanya Hospital

    Paravūr, Kerala, 683513, India

  • Gunjkar Multispeciality Hospital

    Pune, Maharashtra, 4110019, India

  • Lakshmi Nursing Home

    Kochi, Kerala, 683101, India

  • Oxycare Multispecialty Hospital

    Pune, Maharashtra, 411033, India

  • Sparsh Superspeciality Hospital

    Bangalore, Karnataka, 560022, India

  • Vagus Super Specialty Hospital

    Bangalore, Karnataka, 560003, India

Conditions

Explore the condition pages connected to this study.